A5077869256- Musculoskeletal pain and rehabilitation
- Pain Management and Treatment
- Spine and Intervertebral Disc Pathology
- Pain Mechanisms and Treatments
- Anesthesia and Pain Management
- Pain Management and Opioid Use
- Transcranial Magnetic Stimulation Studies
- Myofascial pain diagnosis and treatment
- Botulinum Toxin and Related Neurological Disorders
- Nerve Injury and Rehabilitation
- Shoulder Injury and Treatment
- Pain Management and Placebo Effect
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Cancer Treatment and Pharmacology
- Diversity and Career in Medicine
- Migraine and Headache Studies
- Pediatric Pain Management Techniques
- Spinal Fractures and Fixation Techniques
- Stroke Rehabilitation and Recovery
- Scoliosis diagnosis and treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Orthopedic Infections and Treatments
- Nausea and vomiting management
- Cardiovascular Syncope and Autonomic Disorders
- Innovations in Medical Education
Mayo Clinic in Arizona
2019-2025
WinnMed
2019-2025
Mayo Clinic
2019-2024
Pain and Rehabilitation Medicine
2019-2022
Pain Management Institute
2022
Baylor College of Medicine
2014-2021
Louisiana State University Health Sciences Center Shreveport
2020
Riley Hospital for Children
2020
Indiana University – Purdue University Indianapolis
2020
Yale New Haven Health System
2020
Introduction The evidence for spinal cord stimulation (SCS) has been criticized the absence of blinded, parallel randomized controlled trials (RCTs) and limited evaluations long-term effects SCS in RCTs. aim this study was to determine whether evoked compound action potential (ECAP)-controlled, closed-loop (CL-SCS) is associated with better outcomes when compared fixed-output, open-loop (OL-SCS) 36 months following implant. Methods EVOKE a multicenter, participant-blinded,...
Abstract: Artificial intelligence was introduced 60 years ago and has evolved immensely since that time. While artificial is found in nearly all aspects of our life, the use healthcare industry only recently become apparent more widely discussed. It expected will allow improved disease recognition, treatment optimization, cost time savings, product development, decision making, marketing. For pain medicine specifically, these same benefits be translatable we can expect better recognition...
Introduction: Painful diabetic neuropathy (PDN) is a leading cause of pain and disability globally with lack consensus on the appropriate treatment those suffering from this condition. Recent advancements in both pharmacotherapy interventional approaches have broadened options for PDN. There exists need comprehensive guideline safe effective patients Objective: The SWEET Guideline was developed to provide clinicians most Methods: American Society Pain Neuroscience (ASPN) identified an...
Background: High-frequency (10-kHz) spinal cord stimulation (SCS) continues to be an emerging therapy in chronic pain management. The same complications that plagued earlier SCS systems may affect newer technologies, although there is limited data on the type of and surgical management these complications. Objective: aim this study was systematically examine real-world associated with 10-kHz reported Manufacturer User Facility Device Experience (MAUDE) database. Materials Methods: MAUDE...